Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ACRS Aclaris Therapeutics > Main Composition
ACRS Aclaris Therapeutics
15.510
+0.330+2.17%
Post Mkt Price
15.5100.0000.00%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Contract Research--13.45M198.89%
Therapeutics--932K13.78%
Corporate and Other---7.62M-112.68%
Region Unit:USD
nameYOYOperating income%
United States--6.76M100.00%
Company Overview More
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
CEO: Dr. Neal Walker
Market: NASDAQ
Listing Date: 10/07/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist